Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 29,210 shares at $9.00 ($260K) on 2021-04-08, disclosed to the SEC on 2021-04-12.
Open-market sale of $260k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 9,736 | $88K | 33.7% |
| 2 | $8.87 | 9,737 | $86K | 33.2% |
| 3 | $8.87 | 9,737 | $86K | 33.2% |
| Total | $8.91 avg | 29,210 | $260K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-14 | $169K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |
| DTIL | SELL | 2021-03-12 | $450K | — | Filing → |